University Hospital, Rijeka   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Rijeka Croatia (Hrvatska) (1982)

Organization Overview

First Clinical Trial
2008
NCT01969331
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Clinical Hospital Center Rijeka | Department of Gastroenterology, Clinical Hospital Center Rijeka, University of Rijeka, Croatia | Department of Gastroenterology, University Hospital Rijeka | Goran Hauser | Jadran Galenski laboratorij d.d.Rijeka | Marin Golčić | UH Rijeka | University Hospital Center Rijeka | University Hospital Rijeka | University of medicine Rijeka | University of Rijeka | University of Rijeka, Faculty of Health studies | University of Rijeka, Medical Faculty

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 2)

Fatty Liver (Phase 4)

Liver Diseases (Phase 4)

Non-alcoholic Fatty Liver Disease (Phase 4)

Pancreatitis (Phase 4)

Renal Insufficiency (Phase 4)

Vitamin D Deficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 14
  • # of Trial APIs: 18